Applied DNA Sciences (NASDAQ:APDN) Shares to Reverse Split on Thursday, April 25th

Applied DNA Sciences, Inc. (NASDAQ:APDN)’s stock is set to reverse split on Thursday, April 25th. The 1-20 reverse split was announced on Thursday, April 25th. The number of shares owned by shareholders will be adjusted after the market closes on Thursday, April 25th.

Applied DNA Sciences Stock Performance

APDN stock traded down $0.04 during mid-day trading on Tuesday, reaching $0.29. 811,420 shares of the stock traded hands, compared to its average volume of 116,854. Applied DNA Sciences has a one year low of $0.28 and a one year high of $1.86. The stock has a market capitalization of $4.92 million, a PE ratio of -0.54 and a beta of 0.07. The business has a 50-day moving average price of $0.49 and a two-hundred day moving average price of $0.67.

Applied DNA Sciences (NASDAQ:APDN) last posted its quarterly earnings data on Thursday, February 8th. The technology company reported ($0.09) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.31) by $0.22. Applied DNA Sciences had a negative net margin of 80.14% and a negative return on equity of 159.93%. The business had revenue of $0.89 million for the quarter, compared to analysts’ expectations of $0.70 million. On average, equities analysts expect that Applied DNA Sciences will post -0.63 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on the stock. StockNews.com assumed coverage on shares of Applied DNA Sciences in a research note on Sunday. They set a “hold” rating for the company. HC Wainwright lowered their target price on shares of Applied DNA Sciences from $2.00 to $1.50 and set a “buy” rating for the company in a research note on Friday, February 9th.

Institutional Trading of Applied DNA Sciences

A hedge fund recently bought a new stake in Applied DNA Sciences stock. Silverberg Bernstein Capital Management LLC acquired a new position in Applied DNA Sciences, Inc. (NASDAQ:APDN) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 98,301 shares of the technology company’s stock, valued at approximately $61,000. Silverberg Bernstein Capital Management LLC owned 0.72% of Applied DNA Sciences at the end of the most recent reporting period. 22.22% of the stock is owned by institutional investors.

About Applied DNA Sciences

Applied DNA Sciences, Inc, a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services.